Stay updated on Benralizumab in Chronic Urticaria Clinical Trial

Sign up to get notified when there's something new on the Benralizumab in Chronic Urticaria Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Benralizumab in Chronic Urticaria Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    The page now includes a Locations section with state-level entries (Arizona, California, Florida, Georgia, Michigan, Ohio, Oklahoma, Texas) and the revision tag updated to v3.3.3, while the HHS Vulnerability Disclosure link is removed.
    Difference
    0.7%
    Check dated 2025-12-23T09:18:43.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    No Change Detected
  5. Check
    38 days ago
    Change Detected
    Summary
    Revision: v3.3.2 is now shown on the page, replacing Revision: v3.2.0. There are no changes to the study content or layout.
    Difference
    0.0%
    Check dated 2025-11-24T21:54:43.000Z thumbnail image
  6. Check
    45 days ago
    Change Detected
    Summary
    The government funding/operating status notice has been removed from the page. The study details and requirements remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-17T19:55:46.000Z thumbnail image
  7. Check
    59 days ago
    Change Detected
    Summary
    No significant content changes detected; any differences appear to be minor formatting or layout adjustments that do not affect the study details. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T13:52:46.000Z thumbnail image
  8. Check
    88 days ago
    Change Detected
    Summary
    Added a government operating status notice and a v3.2.0 revision; removed the previous v3.1.0 revision.
    Difference
    2%
    Check dated 2025-10-06T04:35:45.000Z thumbnail image
  9. Check
    95 days ago
    Change Detected
    Summary
    Apparent page reversion to a new version (v3.1.0) while removing several drug-related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) and the prior version reference (v3.0.2).
    Difference
    0.2%
    Check dated 2025-09-29T01:30:50.000Z thumbnail image

Stay in the know with updates to Benralizumab in Chronic Urticaria Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Benralizumab in Chronic Urticaria Clinical Trial page.